Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 940-944, February 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kovacs, E. J.
Right arrow Articles by Young, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kovacs, E. J.
Right arrow Articles by Young, H. A.

Cytokine Gene Expression during the Generation of Human Lymphokine-activated Killer Cells: Early Induction of Interleukin 1ß by Interleukin 21

Elizabeth J. Kovacs2, Suzanne K. Beckner, Dan L. Longo, Luigi Varesio and Howard A. Young

Department of Anatomy, Loyola University, Maywood, Illinois [E. J. K.]; Program Resources, Inc., National Cancer Institute-Frederick Cancer Research Facility, Frederick, Maryland [S. K. B.]; and Laboratory of Molecular Immunoregulation, Biological Response Modifiers Program, Division of Cancer Treatment, National Cancer Institute-Frederick Cancer Research Facility, Frederick, Maryland [D. L. L., L. V., H. A. Y.]

Culture of human peripheral blood leukocytes with interleukin 2 (IL-2) stimulates their differentiation into lymphokine-activated killer (LAK) cells, with a broad range of cytotoxicity against fresh tumor cells and tumor cell lines (Grimm et al., J. Exp. Med., 155: 1823–1841, 1982). We chose to utilize a molecular approach to determine whether IL-2 stimulates the expression of cytokine genes by the mixed cell population which may be involved in the generation or regulation of lytic activity. Northern blot analysis performed with total cellular RNA from LAK cells cultured for varying periods of time with IL-2 revealed that the genes which code for cytokines [interleukin 1 (IL-1){alpha} and ß, {gamma}-interferon, tumor necrosis factor {alpha}, and lymphotoxin] were not spontaneously expressed. As soon as 2 h after IL-2 treatment, IL-1{alpha} and IL-1ß mRNAs were expressed. Both nonadherent and adherent populations of LAK cells express IL-1ß mRNA; however, the adherent population produced more IL-1ß mRNA and maintained its expression for a prolonged period of time. Other cytokine mRNAs ({gamma}-interferon, tumor necrosis factor {alpha}, and lymphotoxin) were expressed later than the IL-1 mRNAs with maximal levels between Days 2 through 7. Our results indicate that LAK cell populations can generate a variety of cytokines which may be involved in the generation of lytic activity.

1 Research sponsored, at least in part, by the National Cancer Institute, Department of Health and Human Services, under Contract NO1-Co-23910 with Program Resources, Inc.

2 To whom requests for reprints should be addressed, at Department of Anatomy, Loyola University Stritch School of Medicine, 2160 South First Avenue, Maywood, IL 60153.

Received 7/12/88. Revised 9/ 6/88. Accepted 11/18/88.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.